Selection criteria for high-density polyethylene bottles

High-density polyethylene is a kind of crystalline plastic, and it is also one of the most widely used types of general-purpose plastics. It can be processed into high-density polyethylene bottles by injection, extrusion, blow molding and other methods and used in pharmaceutical packaging. At present, the quality of HDPE bottles on the market is uneven, and pharmaceutical companies can consider the following aspects when choosing:

HDPE pills bottle

medicine cap

1. The tightness and water vapor permeability of the bottle cap. Whether it is a solid medicine or a liquid medicine, it is necessary to ensure that the bottle has a good sealability and water vapor permeability, so as to better ensure that the medicine is not affected by moisture deterioration or leakage.

2. Quality standards. High-density polyethylene bottles have special national quality standards, and manufacturers will also formulate corporate standards based on their own production conditions. You can analyze the manufacturer's product quality standards to see whether their own standards are higher than the national standards, and the products have more Strict quality requirements.

3. Stability and compatibility of the bottle. Pharmaceutical companies should fully consider the stability and compatibility of the bottle material and the drug when choosing a plastic bottle, and investigate the mutual penetration, adsorption or reaction between the drug and the bottle material. This can be determined by strict testing.

4. Supplier qualification. When pharmaceutical companies choose high-density polyethylene bottles, they inspect their suppliers and make a comprehensive and correct assessment of the factory’s production equipment, technical equipment, and overall quality level to ensure the stability of product quality in the later stages.

HDPE child proof bottles are an important link in the circulation of drugs. The quality of the bottles is related to the safety of drugs and is inseparable from people's health. Pharmaceutical companies should consider multiple aspects when choosing.